Rob Sellar

Company: University College London

Job title: Senior Fellow Clinical Research

Seminars:

Panel Discussion: A Critical Review – What Will it Take to Progress Degraders Towards & Through the Clinic? 2:45 pm

Targeted Protein Degradation continues to progress as a therapeutic with huge potential, and 2023 is shaping up to be a landmark year for the degradation community. With the emergence of over 88 newly disclosed TPD drugs in the first half of 2022, over 67 TPD drug updates and critical collaboration, this community continues to advance…Read more

day: Day Two